IKInna Kaledina

Inna Kaledina

*This is an algorithmically generated author record based on publicly available information.

Inna Kaledina has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Severe Hyponatremia as the First Manifestation of Primary Tracheal Small-cell Carcinoma: A Case Report

    by Inna Kaledina, Heshan Radeesha De Silva, Daria Strelkova, Svetlana Rachina, Vladimir Kuleshov, Auna Shakhaeva

    Introduction: Pleomorphic small-cell tracheal carcinoma, though recognized as a different entity, can present clinically similar to small-cell lung carcinoma.Case Report: We present a rare case of a 60-year-old patient, a previous smoker, who initially presented with syndrome of inappropriate antidiuretic hormone secretion (SIADH) related clinical features and was later diagnosed as having pleomorphic small-cell tracheal carcinoma (SCTC). Being rare, tracheal carcinomas usually present with clinical features related to tracheal obstruction and hemoptysis. Our case initially presented as SIADH and subsequent investigations led to the final diagnosis only at the autopsy, which was later identified as the primary cause of the clinical course that ultimately led to his demise.Conclusion: A high index of suspicion for neuroendocrine tumors should be maintained even when classic respiratory symptoms and imaging findings are absent in high-risk individuals for respiratory cancers.

  • Open Access

    Distinguishing Between Bacterial and Viral Community‐Acquired Pneumonia in Hospitalized Adults: The Importance of Clinical, Laboratory, and Imaging Findings

    by Daria Strelkova, Anastasia Yasneva, Olga Kupriushina, Sergey Avdeev, Anna Vlasenko, Lyudmila Fedina, Olga Ivanova, Ivan Zakharenkov, Inna Kaledina, Nataliia Ananicheva, et al.

    Background: Our study aims to compare patients with identified viral and bacterial pathogens and develop a predictive model for determining community‐acquired pneumonia (CAP) etiology. Methods: In this retrospective case–control study, hospitalized adults with confirmed bacterial or viral CAP were compared at a 1:3 ratio. Patients were matched by gender, hospitalization department, age, and Charlson comorbidity index. The etiology of CAP was established through blood and sputum culture, polymerase chain reaction of respiratory specimens, and urinary antigen tests. Both objective variables and subjective symptoms were assessed using multivariate conditional logistic regression. Results: Our study included 400 patients. Using the best‐developed model, we found that patients with bacterial CAP were more likely to exhibit unilateral infiltration on visualization (odds ratio [OR] 20.47; 95% confidence intervals [CI; 7.51–55.81], p < 0.001), experience chills (OR 20.69; 95% CI [6.08–70.38], p < 0.001), have a higher heart rate (OR 1.04; 95% CI [1.01–1.06], p = 0.001), and demonstrate an elevated neutrophils/lymphocytes ratio (OR 1.58; 95% CI [1.16–2.14], p = 0.003). They also showed a decreased level of consciousness (OR 3.16; [1.16–8.61], p = 0.024), and were more likely to receive vasopressors within the first 24 h of admission (OR 8.28; 95% CI [1.75–39.22], p = 0.008). Conversely, they were less likely to have general weakness (OR 0.20; 95% CI [0.09–0.47], p < 0.001) and tended to have lower total serum protein levels (OR 0.06; 95% CI [0.01–0.45], p = 0.006). This model showed sensitivity of 90%, specificity of 91%, and positive predictive value of 97%. Conclusion: The developed model offers a valuable tool for assessing the etiology of CAP upon admission.

  • Open Access

    Development of a model for the differential diagnosis of community-acquired bacterial pneumonia and viral lung injury in hospitalized adult patients

    by O. A. Kupriushina, D. A. Strelkova, A. S. Yasneva, S. A. Rachina, S. N. Avdeev, A. E. Vlasenko, L. V. Fedina, O. V. Ivanova, I. V. Kaledina, N. A. Ananicheva

    Relevance. During and after the COVID-19 pandemic, viruses have become a more common cause of pulmonary infections in adults; therefore, the distinction between viral lung injury and community-acquired bacterial pneumonia is of increasing importance. Aim. Development of a model for differentiating community-acquired bacterial pneumonia and viral lung injury, including COVID-19. Materials and methods. This retrospective case–control study included 300 adult patients with viral lung injury and 100 adult patients with community-acquired bacterial pneumonia. Clinical, laboratory, and instrumental data were analyzed, significant factors were selected by which the samples differed, and a model was developed using logistic regression to distinguish between community-acquired bacterial pneumonia and viral lung damage, including COVID-19. Results. The developed model included the following parameters: total protein level, neutrophil/lymphocyte index, heart rate, unilateral infiltration on CT or chest x-ray, vasopressor prescription in the first 24 h of hospitalization, altered level of consciousness, chills, and fatigue. The model had the following characteristics: AUC = 0.94 (0.92–0.96), AUC_PR = 0.84 (0.76 to 0.92), prediction accuracy — 90%, sensitivity — 76%, specificity — 95%, positive predictive value — 83 %. Conclusion. The use of this model can facilitate the differential diagnosis of community-acquired bacterial pneumonia and viral lung injury, including COVID-19, in adults in general wards and intensive care units.